MAVS antibody | knockout validation | Santa Cruz sc-166583

This is a knockout-validated antibody summary, based on the publications "TAX1BP1 Restrains Virus-Induced Apoptosis by Facilitating Itch-Mediated Degradation of the Mitochondrial Adaptor MAVS", as cited below [1] and "Hepatitis C virus exploits cyclophilin A to evade PKR" for western blot knockout validation (see [2] figure 6c). Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Mouse monoclonal IgG2a (kappa light chain)

Company: Santa Cruz

Antibody: MAVS

Catalog number: sc-166583

Summary: Mouse monoclonal IgG2a (kappa light chain) against amino acids 1-135 mapping within an N-terminal cytoplasmic domain of human MAVS. Recommended for detection of MAVS of human origin by western blot, immunoprecipitation, immunofluorescence, immunohistochemistry (paraffin) and and ELISA.

Validation Method

Western blot

Sample

Control and MAVS-deficient HeLa cells infected with SeV. Cells were lysed on ice for 1 h in RIPA buffer (50 mM Tris-HCl [3, 4], 150 mM NaCl, 1% Igepal CA-630, 0.25% deoxycholate, 10 mM NaF, and 10 mM Na3VO4) freshly supplemented with protease inhibitor cocktail (Roche Applied Bioscience, Indianapolis, IN).

Primary incubation

Antibodies were diluted in SuperBlock blocking phosphate-buffered saline (PBS) buffer (Thermo Scientific, Rockford, IL).

Detection

Enhanced chemiluminescence (ECL) reagents (Perkin-Elmer).

Figure

Western blot of the indicated proteins in TAX1BP1- and/or MAVS-deficient HeLa cells infected with SeV (25 HA units/ml) for 24 h. Please see Figure 5a in the article [1].

References
  1. Choi Y, Shembade N, Parvatiyar K, Balachandran S, Harhaj E. TAX1BP1 Restrains Virus-Induced Apoptosis by Facilitating Itch-Mediated Degradation of the Mitochondrial Adaptor MAVS. Mol Cell Biol. 2017;37: pubmed publisher
  2. Colpitts C, Ridewood S, Schneiderman B, Warne J, Tabata K, Ng C, et al. Hepatitis C virus exploits cyclophilin A to evade PKR. elife. 2020;9: pubmed publisher
  3. 7.
  4. 4.